Nature Medicine
2026-06-24 00:00
DOI:
HASH:8ced04b4d4cf9058f0ad37dd5ac1fa5a
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
作者:
摘要 / Abstract
该条目无摘要（多为勘误、社论或新闻类内容，出版方未提供摘要）